Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies

G D James, Stefan N Symeonides, J Marshall, J Young, G Clack

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBMC Cancer
Publication statusPublished - 5 Jan 2021

Cite this